Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pin

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Cellular and Molecular Gastroenterology and Hepatology|November 15, 2024
Mouse Models for Pancreatic Ductal Adenocarcinoma are Affected by the cre-driver Used to Promote KRAS<sup>G12D</sup> ActivationFatemeh Mousavi, Joyce Thompson, Justine Lau, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 4, 2015
Deletion of Panx3 Prevents the Development of Surgically Induced OsteoarthritisPaxton M Moon, Silvia Penuela, Kevin Barr, et al.
Cell Death Discovery|November 6, 2025
Acinar-specific loss of activating transcription factor 3 restricts KRAS<sup>G12D</sup> mediated transcriptional changes and PanIN progressionMickenzie B Martin, Fatemeh Mousavi, Gavin Goebel, et al.
The FEBS Journal|August 10, 2025
Defining the interactome of the pancreas-specific SPCA2 isoform (SPCA2C) identifies unique links to store-operated Ca<sup>2+</sup> entryPetra Samardzija, Melissa A Fenech, Oneeb Hassan, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 5, 2018
The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male MiceClaire C Young, Ryan M Baker, Christopher J Howlett, et al.
Molecular Pharmacology|August 3, 2016
A Fibroblast Growth Factor 21-Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver DiseaseSarah J Woolsey, Melanie D Beaton, Sara E Mansell, et al.
Oncogene|April 17, 2021
Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancerNawab Azizi, Jelena Toma, Mickenzie Martin, et al.
Molecular Biology of the Cell|July 14, 2017
Activating transcription factor 3 promotes loss of the acinar cell phenotype in response to cerulein-induced pancreatitis in miceElena N Fazio, Claire C Young, Jelena Toma, et al.
Endocrinology|March 17, 2015
Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21Julia M Assini, Erin E Mulvihill, Amy C Burke, et al.
Cancer Research|January 7, 2006
Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinomaDavid A Tuveson, Liqin Zhu, Aarthi Gopinathan, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Cellular and Molecular Gastroenterology and Hepatology|November 15, 2024
Mouse Models for Pancreatic Ductal Adenocarcinoma are Affected by the cre-driver Used to Promote KRAS<sup>G12D</sup> ActivationFatemeh Mousavi, Joyce Thompson, Justine Lau, et al.
Journal of Molecular Medicine (Berlin, Germany)|July 4, 2015
Deletion of Panx3 Prevents the Development of Surgically Induced OsteoarthritisPaxton M Moon, Silvia Penuela, Kevin Barr, et al.
Cell Death Discovery|November 6, 2025
Acinar-specific loss of activating transcription factor 3 restricts KRAS<sup>G12D</sup> mediated transcriptional changes and PanIN progressionMickenzie B Martin, Fatemeh Mousavi, Gavin Goebel, et al.
The FEBS Journal|August 10, 2025
Defining the interactome of the pancreas-specific SPCA2 isoform (SPCA2C) identifies unique links to store-operated Ca<sup>2+</sup> entryPetra Samardzija, Melissa A Fenech, Oneeb Hassan, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 5, 2018
The Loss of ATRX Increases Susceptibility to Pancreatic Injury and Oncogenic KRAS in Female But Not Male MiceClaire C Young, Ryan M Baker, Christopher J Howlett, et al.
Molecular Pharmacology|August 3, 2016
A Fibroblast Growth Factor 21-Pregnane X Receptor Pathway Downregulates Hepatic CYP3A4 in Nonalcoholic Fatty Liver DiseaseSarah J Woolsey, Melanie D Beaton, Sara E Mansell, et al.
Oncogene|April 17, 2021
Loss of activating transcription factor 3 prevents KRAS-mediated pancreatic cancerNawab Azizi, Jelena Toma, Mickenzie Martin, et al.
Molecular Biology of the Cell|July 14, 2017
Activating transcription factor 3 promotes loss of the acinar cell phenotype in response to cerulein-induced pancreatitis in miceElena N Fazio, Claire C Young, Jelena Toma, et al.
Endocrinology|March 17, 2015
Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21Julia M Assini, Erin E Mulvihill, Amy C Burke, et al.
Cancer Research|January 7, 2006
Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinomaDavid A Tuveson, Liqin Zhu, Aarthi Gopinathan, et al.
Pageof 6